Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Germ Cell Neoplasm”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT00588068
What this trial is testing

Molecular Characterization of Neuroblastic Tumor: Correlation With Clinical Outcome

Who this might be right for
Neuroblastoma
Memorial Sloan Kettering Cancer Center 2,070
Testing effectiveness (Phase 2)UnknownNCT00416559
What this trial is testing

Observation of Young Patients With Localized Neuroblastoma Who Have Undergone Surgery Only

Who this might be right for
Long-term Effects Secondary to Cancer Therapy in ChildrenNeuroblastoma
Children's Cancer and Leukaemia Group 140
Testing effectiveness (Phase 2)Study completedNCT03278379
What this trial is testing

Avelumab in G2-3 NET

Who this might be right for
Neuroendocrine Tumors
Sunnybrook Health Sciences Centre 17
Not applicableLooking for participantsNCT05370079
What this trial is testing

Control Cohort CTRL COH

Who this might be right for
Parkinson's Disease; Amyotrophic Lateral Sclerosis; Glioblastoma; Cancer Without Neurological Disease; Rheumatoid Polyarthritis
Hospices Civils de Lyon 350
Testing effectiveness (Phase 2)UnknownNCT04524208
What this trial is testing

A Trial of Cabozantinib in Patients With Advanced, Low Proliferative NEN G3

Who this might be right for
Neuroendocrine TumorsNeuroendocrine Carcinoma
Karsten Gavenis 45
Testing effectiveness (Phase 2)Study completedNCT00058123
What this trial is testing

Poly-ICLC in Treating Patients With Recurrent or Progressive Anaplastic Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 55
Testing effectiveness (Phase 2)Ended earlyNCT01984892
What this trial is testing

Treatment of Solid Tumors With Intratumoral Hiltonol® (Poly-ICLC)

Who this might be right for
MelanomaSquamous Cell Carcinoma of the Head and NeckSquamous Cell Carcinoma of the Skin+3 more
Nina Bhardwaj 8
Testing effectiveness (Phase 2)Ended earlyNCT00074334
What this trial is testing

TP-38 Toxin in Treating Young Patients With Recurrent or Progressive Supratentorial High-Grade Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Pediatric Brain Tumor Consortium 3
Testing effectiveness (Phase 2)Study completedNCT00109863
What this trial is testing

Hu14.18-Interleukin-2 Fusion Protein in Treating Patients With Advanced Melanoma

Who this might be right for
Melanoma (Skin)
University of Wisconsin, Madison 14
Early research (Phase 1)Active Not RecruitingNCT05640193
What this trial is testing

LN-144 in People With Metastatic Melanoma to the Brain

Who this might be right for
Metastatic Melanoma
Memorial Sloan Kettering Cancer Center 10
Early research (Phase 1)Study completedNCT02202993
What this trial is testing

TAU-2014-1: Mibefradil and Hypofractionated Re-Irradiation Therapy in Recurrent GBM

Who this might be right for
Glioblastoma Multiforme (GBM)
Cavion, Inc. 18
Early research (Phase 1)Study completedNCT00004016
What this trial is testing

Interferon Gamma in Treating Patients With Recurrent or Metastatic Melanoma or Other Solid Tumors

Who this might be right for
Melanoma (Skin)Unspecified Adult Solid Tumor, Protocol Specific
University of Rochester
Testing effectiveness (Phase 2)Active Not RecruitingNCT02650401
What this trial is testing

Study Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment Options

Who this might be right for
Solid TumorsCNS Tumors
Hoffmann-La Roche 69
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07735819
What this trial is testing

Positron Emission Tomography/Computed Tomography (PET/CT) Imaging in Patients Diagnosed With a Glioma

Who this might be right for
Low Grade GliomaGlioblastoma
Barbara Ann Karmanos Cancer Institute 61
Not applicableStudy completedNCT05714371
What this trial is testing

Retrospective Assessment of Adverse Events-related Healthcare Resource Utilization and Costs of Immune Checkpoint Inhibitor and Targeted Therapy for Adjuvant Treatment of Melanoma

Who this might be right for
Melanoma
Novartis Pharmaceuticals 618
Testing effectiveness (Phase 2)Study completedNCT03566199
What this trial is testing

MTX110 by Convection-Enhanced Delivery in Treating Participants With Newly-Diagnosed Diffuse Intrinsic Pontine Glioma

Who this might be right for
Diffuse Intrinsic Pontine Glioma
Sabine Mueller, MD, PhD 7
Testing effectiveness (Phase 2)Active Not RecruitingNCT04881032
What this trial is testing

AGuIX Nanoparticles With Radiotherapy Plus Concomitant Temozolomide in the Treatment of Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma
Centre Jean Perrin 66
Not applicableStudy completedNCT01598597
What this trial is testing

An Observational Pilot Study Evaluating the Feasibility of Conducting Genome-Wide Association Studies Utilizing Subject Provided Information in Subjects With Locally Recurrent or MBC, MCRC, MNSCLC, RGBM or MRCC Treated With Avastin (Bevacizumab) (InVite)

Who this might be right for
Breast CancerColorectal CancerNon-Small Cell Lung Cancer+2 more
Genentech, Inc. 276
Not applicableStudy completedNCT01432860
What this trial is testing

A Comparison of Interventions to Teach Melanoma Patients Skin Self-examination

Who this might be right for
Melanoma
Northwestern University 1,000
Testing effectiveness (Phase 2)Study completedNCT00086879
What this trial is testing

Erlotinib Compared With Temozolomide or Carmustine in Treating Patients With Recurrent Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
European Organisation for Research and Treatment of Cancer - EORTC 110
Next Page